After 100 years, there's finally an effective cancer vaccine. Now comes the push to get them to work in more tumor types.
Five years after being diagnosed with multiple sclerosis, actor Christina Applegate revealed this week that she had been ...
Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes ...
A multiple sclerosis treatment from Novartis cut by a third the rates of relapses that people with the condition have ...
A new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.
Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early ...
As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna ...
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality ...
What state officials scrambling to implement Medicaid work requirements shared behind closed doors at the National ...
As a Boston judge heard a challenge to Medicaid work requirements, state Medicaid directors gathered in Maryland to figure ...
The humbling truth is that forces outside medical care and public health policies must be playing the biggest role in a ...
A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results